🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide bioavailability optimization — 12 month update Page 4

Oral semaglutide bioavailability optimization — 12 month update

jim_asheville Wed, Feb 7, 2024 at 4:58 PM 58 replies 3,516 viewsPage 4 of 12
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Feb 12, 2024 at 7:48 AM#16

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

20 20Dr.LeslieOBGYN, MikeNYC_runner and 17 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Feb 12, 2024 at 11:01 PM#17
PharmacoVig_BOS said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

19 19traveltech_sara, AttorneyGrant, DebRD_ATL and 16 others
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Feb 13, 2024 at 2:14 PM#18
PharmacoVig_BOS said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Thank you for spelling out the reasoning rather than just the conclusion. Printing the relevant bit and taking it with me.

18 18ZaraB_AL, JakeSmashed95, NauseaFreeNow and 15 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Feb 14, 2024 at 5:27 AM#19

From the other side of the consultation, briefly. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

17 17LindaRN_retired, tommy_boulder, hyun_seoul and 14 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 14, 2024 at 8:41 PM#20

Moderator note: a couple of off-topic posts removed. Report rather than reply if it drifts again.

45 20PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 42 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register